Literature DB >> 33737696

A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients.

Yuzi Xu1, Fengqin Xu2, Yiming Lv3, Siyuan Wang1, Jia Li1, Chuan Zhou1, Jimin Jiang1, Binbin Xie4, Fuming He5.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is one of the most malignant cancers with poor prognosis worldwide. Emerging evidence indicates that competing endogenous RNAs (ceRNAs) are involved in various diseases, however, the regulatory mechanisms of ceRNAs underlying HNSCC remain unclear. In this study, we retrieved differentially expressed long non-coding RNAs (DElncRNAs), messenger RNAs (DEmRNAs) and microRANs (DEmiRNAs) from The Cancer Genome Atlas database and constructed a ceRNA-based risk model in HNSCC by integrated bioinformatics approaches. Functional enrichment analyses showed that DEmRNAs might be involved in extracellular matrix related biological processes, and protein-protein interaction network further selected out prognostic genes, including MYL1 and ACTN2. Importantly, co-expressed RNAs identified by weighted co-expression gene network analysis constructed the ceRNA networks. Moreover, AC114730.3, AC136375.3, LAT and RYR3 were highly correlated to overall survival of HNSCC by Kaplan-Meier method and univariate Cox regression analysis, which were subsequently implemented multivariate Cox regression analysis to build the risk model. Our study provides a deeper understanding of ceRNAs on the regulatory mechanisms, which will facilitate the expansion of the roles on the ceRNAs in the tumorigenesis, development and treatment of HNSCC.

Entities:  

Year:  2021        PMID: 33737696     DOI: 10.1038/s41598-021-86048-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  53 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 2.  Head and Neck Cancer.

Authors:  Laura Q M Chow
Journal:  N Engl J Med       Date:  2020-01-02       Impact factor: 91.245

Review 3.  The molecular landscape of head and neck cancer.

Authors:  C René Leemans; Peter J F Snijders; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

4.  Distant metastases in head and neck cancer.

Authors:  Fréderic Duprez; Dieter Berwouts; Wilfried De Neve; Katrien Bonte; Tom Boterberg; Philippe Deron; Wouter Huvenne; Sylvie Rottey; Marc Mareel
Journal:  Head Neck       Date:  2017-06-26       Impact factor: 3.147

5.  Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers.

Authors:  Samuel J Gan; Kristina R Dahlstrom; Brandon W Peck; Wes Caywood; Guojun Li; Qingyi Wei; Mark E Zafereo; Erich M Sturgis
Journal:  Cancer       Date:  2013-04-19       Impact factor: 6.860

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 7.  Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review.

Authors:  Alessandro Guidi; Carla Codecà; Daris Ferrari
Journal:  Med Oncol       Date:  2018-02-13       Impact factor: 3.738

Review 8.  Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics.

Authors:  Avencia Sanchez-Mejias; Yvonne Tay
Journal:  J Hematol Oncol       Date:  2015-03-28       Impact factor: 17.388

9.  MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4.

Authors:  Hersi Mohamed Hersi; Nina Raulf; Joop Gaken; Najeem'deen Folarin; Mahvash Tavassoli
Journal:  Mol Oncol       Date:  2018-10-25       Impact factor: 6.603

Review 10.  uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.

Authors:  Miguel Angel Pavón; Irene Arroyo-Solera; Maria Virtudes Céspedes; Isolda Casanova; Xavier León; Ramón Mangues
Journal:  Oncotarget       Date:  2016-08-30
View more
  4 in total

1.  Identification of a novel ceRNA network related to prognosis and immunity in HNSCC based on integrated bioinformatic investigation.

Authors:  Hongbo Liu; Guoli Hei; Lu Zhang; Yanxia Jiang; Haijun Lu
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

2.  Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma.

Authors:  Shigeo Ishikawa; Masahiro Sugimoto; Tsuneo Konta; Kenichiro Kitabatake; Shohei Ueda; Kaoru Edamatsu; Naoki Okuyama; Kazuyuki Yusa; Mitsuyoshi Iino
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

3.  The Role of Arginine Metabolism in Oral Tongue Squamous Cell Carcinoma.

Authors:  Leanne Lee Leung; Nicolas Cheuk Hang Lau; Jiaxun Liu; Xinyu Qu; Stephen Kwok-Wing Tsui; Jinpao Hou; Cherie Tsz-Yiu Law; Tung Him Ng; Judy Wai Ping Yam; Chit Chow; Amy B W Chan; Jason Y K Chan; Katie Meehan
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

4.  Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes.

Authors:  Chunyu Feng; Shaopeng Liu; Zhengjun Shang
Journal:  Front Cell Dev Biol       Date:  2022-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.